Gilgamesh Pharma Inc. — Form D
Gilgamesh Pharma Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2026-02-04. The offering totals $6.1M, of which $6.1M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2026-02-04
- Form: D
- Accession: 0002107396-26-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $6.1M
- Amount sold: $6.1M
- Minimum investment: $28K
- Investors: 9
- Date of first sale: 2026-01-02
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-572361
Issuer
- Name: Gilgamesh Pharma Inc.
- CIK: 0002107396
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2025
- Address: 113 UNIVERSITY PLACE, SUITE 1019, NEW YORK, NY, 10003
- Phone: 929-723-4861
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Amy Kruse | Director | New York, NY |
| Zia Huque | Director | New York, NY |
| Robert Berman | Director | New York, NY |
| Phil Skolnick | Director | New York, NY |
| Jonathan Sporn | Director | New York, NY |
| Jonathan Sporn | Executive Officer | New York, NY |
| Andrew Kruegel | Director | New York, NY |
| Andrew Kruegel | Executive Officer | New York, NY |
Other filings by this issuer (3)
More